Infectious Disease Trials
Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.
Page 1 of 1 | Results 1 - 4 of 4
The purpose of this study is to evaluate the safety and potential efficacy signal of the study drug, BMS-936559, in subjects with severe sepsis.
Tidswell, Mark, MD
Infection
Baystate Medical Center 759 Chestnut Street Springfield, MA 01199
The purpose of this study is to compare safety, efficacy, and tolerability of a two drug regimen of dolutegravir (DTG) plus (+) lamivudine (3TC) administered once daily to the DTG plus Tenofovir [TDF]/Emtricitabine [FTC] fixed dose combination [FDC] administered once daily in human immunodeficiency virus (HIV) 1 infected adult subjects that have not previously received antiretroviral therapy. The study is designed to demonstrate the non-inferior antiviral activity of DTG plus 3TC regimen to that of DTG plus TDF/FTC FDC.
Dr. Daniel Skiest
Infection,
HIV
Baystate Medical Center 759 Chestnut Street Springfield, MA 01199
The purpose of this study is to obtain DNA of people who may have the flu in order to better understand the gene response to those that have a high risk of getting the flu.
Armando Paez, MD
Infection
Baystate Infectious Diseases Clinical Research
3300 Main St.
Springfield, MA 01104
The purpose of this study is to determine if sedation of mechanically ventilated severely septic patients with dexmedetomidine have improved outcomes compared to patients on propofol.
Bogden Tiru, MD
Infection
Baystate Medical Center
Critical Care Unit
759 Chestnut St
Springfield, MA 01199
Page 1 of 1 | Results 1 - 4 of 4